DWA
TMO icon

Douglass Winthrop Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Douglass Winthrop Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Sell
24,843
-6
-0% -$3.26K 0.22% 46
2025
Q4 		$14.4M Sell
24,849
-358
-1% -$202K 0.25% 44
2025
Q3 		$12.2M Buy
25,207
+851
+3% +$396K 0.21% 46
2025
Q2 		$9.88M Sell
24,356
-1,522
-6% -$636K 0.18% 50
2025
Q1 		$12.9M Buy
25,878
+545
+2% +$295K 0.25% 43
2024
Q4 		$13.2M Sell
25,333
-35
-0.1% -$19.2K 0.26% 42
2024
Q3 		$15.7M Buy
25,368
+1,178
+5% +$697K 0.3% 38
2024
Q2 		$13.4M Sell
24,190
-1,401
-5% -$803K 0.27% 41
2024
Q1 		$14.9M Buy
25,591
+197
+0.8% +$111K 0.31% 40
2023
Q4 		$13.5M Buy
25,394
+2,180
+9% +$1.06M 0.3% 39
2023
Q3 		$11.8M Buy
23,214
+2,350
+11% +$1.25M 0.29% 39
2023
Q2 		$10.9M Buy
20,864
+3
+0% +$1.62K 0.26% 41
2023
Q1 		$12M Buy
20,861
+512
+3% +$289K 0.31% 39
2022
Q4 		$11.2M Buy
20,349
+59
+0.3% +$31.3K 0.31% 41
2022
Q3 		$10.3M Buy
20,290
+142
+0.7% +$79.5K 0.31% 36
2022
Q2 		$10.9M Sell
20,148
-83
-0.4% -$45.7K 0.31% 38
2022
Q1 		$11.9M Buy
20,231
+1,782
+10% +$1.02M 0.28% 41
2021
Q4 		$12.3M Buy
18,449
+1,501
+9% +$937K 0.28% 42
2021
Q3 		$9.68M Buy
16,948
+1,078
+7% +$592K 0.24% 44
2021
Q2 		$8.01M Buy
15,870
+1,026
+7% +$484K 0.2% 43
2021
Q1 		$6.78M Buy
14,844
+1,187
+9% +$567K 0.18% 47
2020
Q4 		$6.36M Buy
13,657
+1,122
+9% +$526K 0.18% 47
2020
Q3 		$5.53M Buy
12,535
+279
+2% +$115K 0.18% 49
2020
Q2 		$4.44M Buy
12,256
+643
+6% +$216K 0.17% 54
2020
Q1 		$3.29M Buy
11,613
+664
+6% +$209K 0.15% 59
2019
Q4 		$3.56M Buy
10,949
+3,091
+39% +$937K 0.13% 69
2019
Q3 		$2.29M Buy
7,858
+619
+9% +$177K 0.09% 83
2019
Q2 		$2.13M Buy
7,239
+903
+14% +$249K 0.09% 86
2019
Q1 		$1.73M Sell
6,336
-60
-0.9% -$14.9K 0.08% 92
2018
Q4 		$1.43M Buy
6,396
+846
+15% +$198K 0.07% 101
2018
Q3 		$1.35M Buy
5,550
+39
+0.7% +$8.97K 0.06% 107
2018
Q2 		$1.14M Buy
5,511
+17
+0.3% +$3.61K 0.05% 137
2018
Q1 		$1.13M Buy
5,494
+101
+2% +$21.2K 0.06% 138
2017
Q4 		$1.02M Sell
5,393
-404
-7% -$77.4K 0.06% 126
2017
Q3 		$1.1M Buy
5,797
+62
+1% +$11.2K 0.06% 117
2017
Q2 		$1M Sell
5,735
-4,476
-44% -$752K 0.06% 119
2017
Q1 		$1.57M Sell
10,211
-2,346
-19% -$359K 0.1% 96
2016
Q4 		$1.77M Sell
12,557
-10
-0.1% -$1.47K 0.12% 84
2016
Q3 		$2M Sell
12,567
-23,942
-66% -$3.69M 0.14% 76
2016
Q2 		$5.39M Sell
36,509
-23,319
-39% -$3.44M 0.38% 53
2016
Q1 		$8.47M Buy
59,828
+13,145
+28% +$1.76M 0.61% 41
2015
Q4 		$6.62M Buy
46,683
+29,498
+172% +$3.93M 0.49% 49
2015
Q3 		$2.1M Buy
17,185
+8,917
+108% +$1.16M 0.17% 83
2015
Q2 		$1.11M Hold
8,268
– – 0.09% 114
2015
Q1 		$1.11M Buy
+8,268
New +$1.07M 0.09% 114

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Douglass Winthrop Advisors's TMO Position: Q1 2026 in Review

Douglass Winthrop Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.02% in Q1 2026, selling an estimated $3.26K and leaving 24,843 shares worth $12.2M. The position accounts for 0.22% of the portfolio, ranked #46.

Douglass Winthrop Advisors first reported a position in TMO in Q1 2015 and has held it in 45 quarters since. The position peaked at $15.7M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Douglass Winthrop Advisors held 24,843 shares of Thermo Fisher Scientific worth $12.2M as of Q1 2026.
  • Douglass Winthrop Advisors sold 6 Thermo Fisher Scientific shares in Q1 2026, an estimated $3.26K.
  • Thermo Fisher Scientific made up 0.22% of Douglass Winthrop Advisors's portfolio in Q1 2026, its #46 holding.
  • Douglass Winthrop Advisors first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 45 quarters since.
  • Douglass Winthrop Advisors's Thermo Fisher Scientific position peaked at $15.7M in Q3 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Douglass Winthrop Advisors's 13F filing for Q1 2026, filed 14 May 2026.